EPIX Pharmaceuticals Selected To Participate In Panel Session On New Alzheimer’s Disease Treatments At 2006 Biotechnology Industry Organization (BIO) Investor Forum

LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) today announced that it has been selected to participate in a panel session on new Alzheimer’s disease treatments at the 2006 BIO Investor Forum at the Palace Hotel in San Francisco, California on Thursday, October 19, 2006.

MORE ON THIS TOPIC